Dou-Sheng Bai (Rui Peng)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 2

Top Topics

Patient Reported

Epithelial Mesenchymal Transition

Peritoneal Dialysis

Top Venues

Hepatology communications

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Dou-Sheng Bai, Jun Cao, Chi Zhang, Jie Zhou, Bing-Bing Su, Dao-Yuan Tu, Guo-Qing Jiang, Sheng-Jie Jin, Ya-Ping Xu, Dou-Sheng Bai
In vivo CRISPR screen identifies LTN1 as a novel tumor suppressor ubiquitinating insulin-like growth factor 2 mRNA-binding protein 1 in hepatocellular carcinoma. Hepatology communications 7 (10) (2023)
Rui Peng, Peng-Fei Zhang, Chi Zhang, Xiao-Yong Huang, Yan-Bing Ding, Bin Deng, Dou-Sheng Bai, Ya-Ping Xu
Elevated TRIM44 promotes intrahepatic cholangiocarcinoma progression by inducing cell EMT via MAPK signaling. Cancer medicine 7 (3) (2018)